BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Samson WK, Resch ZT. The hypocretin/orexin story. Trends Endocrinol Metab 2000;11:257-62. [PMID: 10920381 DOI: 10.1016/s1043-2760(00)00273-3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Nakajima K, Suwa K, Toyama K. Age-dependent changes in the association between sleep duration and impaired glucose metabolism. World J Diabetes 2017; 8(8): 397-406 [PMID: 28861177 DOI: 10.4239/wjd.v8.i8.397] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
2 Morina IY, Aristakesyan EA, Kuzik VV, Oganesyan GA, Alekseeva OS. On the influence of prenatal hypoxia on formation of the orexinergic system and sleep–wake cycle in early ontogenesis of rats. J Evol Biochem Phys 2016;52:238-45. [DOI: 10.1134/s0022093016030066] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
3 Ebrahim IO, Howard RS, Kopelman MD, Sharief MK, Williams AJ. The hypocretin/orexin system. J R Soc Med 2002;95:227-30. [PMID: 11983761 DOI: 10.1258/jrsm.95.5.227] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
4 D'Anna KL, Gammie SC. Hypocretin-1 dose-dependently modulates maternal behaviour in mice. J Neuroendocrinol 2006;18:553-66. [PMID: 16867176 DOI: 10.1111/j.1365-2826.2006.01448.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 2.0] [Reference Citation Analysis]
5 Grassi D, Marraudino M, Garcia-Segura LM, Panzica GC. The hypothalamic paraventricular nucleus as a central hub for the estrogenic modulation of neuroendocrine function and behavior. Front Neuroendocrinol 2022;65:100974. [PMID: 34995643 DOI: 10.1016/j.yfrne.2021.100974] [Reference Citation Analysis]
6 Yang B, Samson WK, Ferguson AV. Excitatory effects of orexin-A on nucleus tractus solitarius neurons are mediated by phospholipase C and protein kinase C. J Neurosci 2003;23:6215-22. [PMID: 12867505 [PMID: 12867505 DOI: 10.1523/jneurosci.23-15-06215.2003] [Cited by in Crossref: 67] [Article Influence: 3.5] [Reference Citation Analysis]
7 Kolar GR, Grote SM, Yosten GL. Targeting orphan G protein-coupled receptors for the treatment of diabetes and its complications: C-peptide and GPR146. J Intern Med 2017;281:25-40. [PMID: 27306986 DOI: 10.1111/joim.12528] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
8 Ferguson AV, Latchford KJ, Samson WK. The paraventricular nucleus of the hypothalamus - a potential target for integrative treatment of autonomic dysfunction. Expert Opin Ther Targets. 2008;12:717-727. [PMID: 18479218 DOI: 10.1517/14728222.12.6.717] [Cited by in Crossref: 161] [Cited by in F6Publishing: 149] [Article Influence: 11.5] [Reference Citation Analysis]
9 Milasta S, Evans NA, Ormiston L, Wilson S, Lefkowitz RJ, Milligan G. The sustainability of interactions between the orexin-1 receptor and beta-arrestin-2 is defined by a single C-terminal cluster of hydroxy amino acids and modulates the kinetics of ERK MAPK regulation. Biochem J 2005;387:573-84. [PMID: 15683363 DOI: 10.1042/BJ20041745] [Cited by in Crossref: 58] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]